Mimotopes-001
Solid Tumours (NY-ESO-1 positive)
Phase 1/2Active
Key Facts
About Mimotopes
A peptide‑mimotope platform company creates targeted vaccines and diagnostics for oncology and immunology.
View full company profileSolid Tumours (NY-ESO-1 positive)
A peptide‑mimotope platform company creates targeted vaccines and diagnostics for oncology and immunology.
View full company profile